Literature DB >> 849648

The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis.

H Kitamura, K Nagaki, K Inoshita, K Iida, S Inai.   

Abstract

The mechanism responsible for making the differences between plasma and serum complement (CH50) was studied on eight patients with hepatitis-B(s) antigen negative alcoholic liver cirrhosis. CH50 and C4 activities of the sera of all patients were equal to those of the corresponding EDTA-plasma, when sera wre separated after clotting the blood at 37 degrees C. CH50 and C4 activities of the sera, prepared at 21 degrees C or 4 degrees C, from four of eight patients were very low. When serum from one of these four patients was added to normal human serum, C4 activity of the serum mixture markedly decreased at 4 degrees C but not at 37 degrees C. The inactivation of C4 was prevented by adding EDTA or heparin to the serum mixture. These results indicated that very low complement in the sera, prepared at 21 degrees C or 4 degrees C, of the four cases were due to the cold activation of the classical complement pathway.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849648      PMCID: PMC1540919     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  5 in total

1.  Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides.

Authors:  K Nagaki; S Inai
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

2.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

3.  Bithermic complement activation in cryoglobulinaemic serum.

Authors:  U Rother; K Rother; H D Flad; P A Miescher
Journal:  Eur J Clin Invest       Date:  1972-01       Impact factor: 4.686

4.  The complement system in cryoglobulinaemia. Interaction with immunoglobulins and lipoproteins.

Authors:  W D Linscott; J P Kane
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

5.  Serum complement levels in patients with mixed (IgM-IgG) cryoglobulinaemia.

Authors:  G Riethmüller; M Meltzer; E Franklin; P A Miescher
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

  5 in total
  3 in total

1.  Cold-dependent activation of complement: recognition, assessment, and mechanism.

Authors:  K P Mathews; R A Mentyka; S L Chambers; T E Hugli; J H Herschbach; B L Zuraw
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

2.  The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.

Authors:  K Ueda; H Nakajima; T Nakagawa; A Shimizu
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

3.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.